Cargando…

Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection

Fc-mediated virus entry has been observed for many viruses, but the characterization of this activity in convalescent plasma against SARS-CoV-2 Variants of Concern (VOC) is undefined. In this study, we evaluated Fc-mediated viral entry (FVE) on FcγRIIa-expressing HEK293 cells in the presence of SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wieczorek, Lindsay, Zemil, Michelle, Merbah, Mélanie, Dussupt, Vincent, Kavusak, Erin, Molnar, Sebastian, Heller, Jonah, Beckman, Bradley, Wollen-Roberts, Suzanne, Peachman, Kristina K., Darden, Janice M., Krebs, Shelly, Rolland, Morgane, Peel, Sheila A., Polonis, Victoria R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193970/ https://www.ncbi.nlm.nih.gov/pubmed/35711449 http://dx.doi.org/10.3389/fimmu.2022.901217

Ejemplares similares

Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine
por: Li, Yifan, et al.
Publicado: (2023)

Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission
por: Barrows, Brittani M., et al.
Publicado: (2022)

P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay
por: Peachman, K, et al.
Publicado: (2009)

Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
por: Jensen, Jaime L., et al.
Publicado: (2023)

Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates
por: Gao, G, et al.
Publicado: (2012)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
por: Dussupt, Vincent, et al.
Publicado: (2021)

Novel monoclonal antibodies to the SERINC5 HIV-1 restriction factor detect endogenous and virion-associated SERINC5
por: Molnar, Sebastian, et al.
Publicado: (2020)

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions
por: Beck, Zoltan, et al.
Publicado: (2009)

Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters
por: King, Hannah A. D., et al.
Publicado: (2023)

Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design
por: Wieczorek, L, et al.
Publicado: (2012)

Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide
por: Matyas, GR, et al.
Publicado: (2012)

The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
por: Cincotta, CD Macedo, et al.
Publicado: (2012)

P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
por: Weaver, KL, et al.
Publicado: (2009)

A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity
por: González-Feliciano, José A., et al.
Publicado: (2020)

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
por: Kuriakose Gift, Syna, et al.
Publicado: (2023)

Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand
por: Li, Yifan, et al.
Publicado: (2022)

A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells
por: Eller, Michael A., et al.
Publicado: (2011)

Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform
por: Chaudhury, Sidhartha, et al.
Publicado: (2021)

Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population
por: Gromowski, Gregory D., et al.
Publicado: (2023)

Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples
por: Lakhal-Naouar, Ines, et al.
Publicado: (2023)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)

Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype
por: Song, Hongshuo, et al.
Publicado: (2023)

Validation of SARS-CoV-2 pooled testing for surveillance using the Panther Fusion(®) system: Impact of pool size, automation, and assay chemistry
por: Park, Rudolph, et al.
Publicado: (2022)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters
por: Wuertz, Kathryn McGuckin, et al.
Publicado: (2021)

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
por: Kasturirangan, Srinath, et al.
Publicado: (2017)

Entry of viruses through the epithelial barrier: pathogenic trickery
por: Bomsel, Morgane, et al.
Publicado: (2003)

Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer
por: Stanbridge, Lindsay J., et al.
Publicado: (2003)

Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
por: Dussupt, Vincent, et al.
Publicado: (2021)

T(FH) cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1
por: Allam, Atef, et al.
Publicado: (2015)

Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth
por: Li, Yifan, et al.
Publicado: (2021)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
por: Mitchell, Julie L., et al.
Publicado: (2022)

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
por: Chenine, A, et al.
Publicado: (2009)

Frequent Hepatitis E Virus Contamination in Food Containing Raw Pork Liver, France
por: Pavio, Nicole, et al.
Publicado: (2014)

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
por: Om, Kier, et al.
Publicado: (2020)

Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection
por: Blanco, Jorge CG, et al.
Publicado: (2009)

The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7otevldbsr6oo8aq5ntvl1cjvb